Trademark: 90886631
Word
ELLIPSES
Status
Pending
Status Code
653
Status Date
Friday, November 25, 2022
Serial Number
90886631
Mark Type
4
Filing Date
Tuesday, August 17, 2021

Trademark Owner History

Classifications
5 Pharmaceutical preparations for the treatment of cancer; veterinary preparations for the treatment of cancer; dietetic preparations for medical purposes; dietetic foods for use in clinical nutrition; food supplements; nutraceuticals for therapeutic and medical purposes; medicated food supplements; biological preparations for the treatment of cancer; anti-cancer preparations; anti-cancer drugs being preparations; compounds for treating cancer being pharmaceutical preparations; biopharmaceuticals for the treatment of cancer; anti-cancer preparations of chemical origin; anti-cancer preparations of plant origin; anti-cancer preparations of microbial origin; pharmaceutical preparations for the treatment of cancer; anti-cancer preparations from hormones and antagonists; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical preparations and substances for the treatment of cancer; all of the aforesaid for use in oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to cancer
42 Medical and pharmacological research services; biological research; clinical research in the field of oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and surgery in relation to cancer; medical research; providing an online network environment for research and development for drug and pharmaceutical development; providing an online network environment for the design, development and testing of drugs and pharmaceuticals; Providing scientific and technological services and research, analysis, and design relating thereto; design, development and testing of drugs and pharmaceuticals for the treatment and/or prevention of cancer; laboratory research into new drugs and pharmaceutical products; pharmaceutical drug development services; research relating into medicines; consultancy services relating to scientific and medical research; expert advice relating to drug development, being consulting services in the field of pharmaceutical research; laboratory analysis in the field of pharmaceutical research; computer hardware and software design and development in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; computer network services in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; software hosting services in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; software as a service in relation to oncology, surgical oncology, radiation therapy, chemotherapy, hormonal therapy, immunotherapy, radiotherapy, targeted cancer therapy, and the prevention, diagnosis, treatment, management of, and/or surgery in relation to, cancer; Information Technology (IT) consultancy, advisory and information services relating to a network of medical research professionals; scientific advisory services; scientific research projects and studies being scientific research and development; conducting clinical trials being scientific and medical research for others; scientific and medical clinical research for others; clinical research for cancer treatments and pharmaceuticals; providing an online network environment for clinical trials; conducting and collating a research network for treatment, cure and prevention of cancer being medical and scientific research; development of measuring and testing methods being research and development in the field of pharmaceuticals; quality control of services; evaluation of drug development services; industrial testing, namely, industrial design services; pharmaceutical product evaluation; testing of chemicals

Trademark Events
May 23, 2022
Non-Final Action Written
Aug 20, 2021
New Application Entered
Oct 5, 2021
New Application Office Supplied Data Entered
May 18, 2022
Assigned To Examiner
May 23, 2022
Non-Final Action E-Mailed
May 23, 2022
Notification Of Non-Final Action E-Mailed
Nov 24, 2022
Teas/Email Correspondence Entered
Nov 23, 2022
Correspondence Received In Law Office
Nov 23, 2022
Teas Response To Office Action Received
Nov 25, 2022
Suspension Letter Written
Nov 25, 2022
Letter Of Suspension E-Mailed
Nov 25, 2022
Notification Of Letter Of Suspension E-Mailed
May 7, 2024
Teas Response To Suspension Inquiry Received
May 8, 2024
Suspension Checked - To Attorney For Action
Dec 29, 2023
Suspension Checked - To Attorney For Action
Jun 8, 2023
Suspension Checked - To Attorney For Action

Trademark Alertz updated from USPTO on 2030-01-24